Laurel Richie
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Hasbro Set to Report Q3 2026 Earnings on October 20. Hasbro is scheduled to announce its third-quarter 2026 earnings on October 20, 2026. Recent commentary suggests the company may continue to outperform market estimates, while its 6.07% dividend yield remains a focal point for income-focused observers. The stock currently trades near its 52-week high, reflecting steady performance relative to broader market returns.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
BMO Lowers Bright Horizons Price Target to $83. BMO Capital maintained its Outperform rating on Bright Horizons but lowered its price target to $83. This action follows a broader review of consumer discretionary education stocks after their second-quarter results. The new target sits below the current average analyst estimate of $88.11, reflecting a more conservative outlook for the company's near-term performance.
Transaction History
| SYF | ▲ Buy | Grant | 846 | $60K | 9/30/2026 | View on chart |
| SYF | ▲ Buy | Grant | 138 | $11K | 8/17/2026 | View on chart |
| SYF | ▲ Buy | Grant | 789 | $60K | 6/30/2026 | View on chart |
| HAS | ▲ Buy | Grant | 2,224 | $0 | 6/11/2026 | View on chart |
| BFAM | ▲ Buy | Grant | 2,096 | — | 6/3/2026 | View on chart |
| SYF | ▲ Buy | Grant | 135 | $10K | 5/15/2026 | View on chart |
| SYF | ▲ Buy | Grant | 883 | $60K | 3/31/2026 | View on chart |
| SYF | ▲ Buy | Grant | 129 | $9K | 2/17/2026 | View on chart |
| SYF | ▲ Buy | Grant | 660 | $55K | 12/31/2025 | View on chart |
| SYF | ▲ Buy | Grant | 130 | $9K | 11/17/2025 | View on chart |
| SYF | ▲ Buy | Grant | 775 | $55K | 9/30/2025 | View on chart |
| SYF | ▲ Buy | Grant | 125 | $9K | 8/15/2025 | View on chart |
| SYF | ▲ Buy | Grant | 825 | $55K | 6/30/2025 | View on chart |
| BFAM | ▲ Buy | Grant | 976 | — | 6/3/2025 | View on chart |
| HAS | ▲ Buy | Grant | 2,611 | $0 | 5/21/2025 | View on chart |
| SYF | ▲ Buy | Grant | 143 | $9K | 5/15/2025 | View on chart |
| SYF | ▲ Buy | Grant | 1,039 | $55K | 3/31/2025 | View on chart |
| SYF | ▲ Buy | Grant | 107 | $7K | 2/18/2025 | View on chart |
| SYF | ▲ Buy | Grant | 635 | $41K | 12/31/2024 | View on chart |
| SYF | ▲ Buy | Grant | 105 | $7K | 11/15/2024 | View on chart |
| SYF | ▲ Buy | Grant | 827 | $41K | 9/30/2024 | View on chart |
| SYF | ▲ Buy | Grant | 23 | $1K | 8/15/2024 | View on chart |
| SYF | ▲ Buy | Grant | 875 | $41K | 6/30/2024 | View on chart |
| BFAM | ▲ Buy | Grant | 902 | — | 6/5/2024 | View on chart |
| HAS | ▲ Buy | Grant | 2,923 | $0 | 5/16/2024 | View on chart |
| SYF | ▲ Buy | Grant | 26 | $1K | 5/15/2024 | View on chart |
| SYF | ▲ Buy | Grant | 957 | $41K | 3/31/2024 | View on chart |
| SYF | ▲ Buy | Grant | 33 | $1K | 2/15/2024 | View on chart |
| SYF | ▲ Buy | Grant | 1,081 | $41K | 12/31/2023 | View on chart |
| SYF | ▲ Buy | Grant | 45 | $1K | 11/9/2023 | View on chart |
| SYF | ▲ Buy | Grant | 1,350 | $41K | 9/30/2023 | View on chart |
| SYF | ▲ Buy | Grant | 39 | $1K | 8/10/2023 | View on chart |
| SYF | ▲ Buy | Grant | 1,217 | $41K | 6/30/2023 | View on chart |
| BFAM | ▲ Buy | Grant | 1,087 | — | 6/21/2023 | View on chart |
| HAS | ▲ Buy | Grant | 2,838 | $0 | 5/18/2023 | View on chart |
| SYF | ▲ Buy | Grant | 48 | $1K | 5/12/2023 | View on chart |
| SYF | ▲ Buy | Grant | 1,419 | $41K | 3/31/2023 | View on chart |
| SYF | ▲ Buy | Grant | 35 | $1K | 2/17/2023 | View on chart |
| SYF | ▲ Buy | Grant | 1,256 | $41K | 12/31/2022 | View on chart |
| SYF | ▲ Buy | Grant | 30 | $1K | 11/10/2022 | View on chart |
| SYF | ▲ Buy | Grant | 1,464 | $41K | 9/30/2022 | View on chart |
| SYF | ▲ Buy | Grant | 28 | $1K | 8/11/2022 | View on chart |
| SYF | ▲ Buy | Grant | 1,494 | $41K | 6/30/2022 | View on chart |
| BFAM | ▲ Buy | Grant | 1,299 | — | 6/22/2022 | View on chart |
| HAS | ▲ Buy | Grant | 1,975 | $0 | 6/8/2022 | View on chart |
| SYF | ▲ Buy | Grant | 24 | $793 | 5/12/2022 | View on chart |
| SYF | ▲ Buy | Grant | 1,186 | $41K | 3/31/2022 | View on chart |
| SYF | ▲ Buy | Grant | 17 | $742 | 2/17/2022 | View on chart |
| SYF | ▲ Buy | Grant | 890 | $41K | 12/31/2021 | View on chart |
| SYF | ▲ Buy | Grant | 15 | $753 | 11/12/2021 | View on chart |
| SYF | ▲ Buy | Grant | 844 | $41K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Synchrony Financial Prepares for Q3 Earnings Amid Mixed Analyst Views
Synchrony Financial is approaching its third-quarter earnings report, with analysts expecting lower results compared to previous periods. While some market participants are watching for higher purchase volumes to support performance, recent stock price movements have been volatile. The company's current valuation remains low relative to its peer group, and its preferred shares have seen increased interest due to yield.
Synchrony Financial Prepares for Q3 Earnings Amid Mixed Analyst Views. Synchrony Financial is approaching its third-quarter earnings report, with analysts expecting lower results compared to previous periods. While some market participants are watching for higher purchase volumes to support performance, recent stock price movements have been volatile. The company's current valuation remains low relative to its peer group, and its preferred shares have seen increased interest due to yield.